Partner with PharmaMar

PharmaMar has a history of successful collaborations with market leaders all over the world. We believe the foundation of a successful partnership is mutual respect of each other’s goals and capabilities. Partnering means succeeding together.

Partnering with PharmaMar

Partnering with PharmaMar

We have partnerships all around the world

In the last 10 years, PharmaMar has been partnering with companies around the world.

History of Collaboration

Yondelis

  • Janssen
  • Valeo Pharma
  • Immedica
  • R-Pharm
  • TTY Biopharm
  • Onco Kocsel
  • Mega Pharm

  • Taiho Pharma
  • Specialised Therapeutics
  • Adium Pharma
  • Stada
  • Genesis Pharma
  • KEY Oncologics

Zepzelca

  • Jazz Pharmaceuticals
  • Immedica
  • Adium Pharma
  • Boryung Pharma

  • Specialised Therapeutics
  • Luye Pharma
  • Mega Pharm
  • Lotus Pharma

Aplidin

  • Specialised Therapeutics
  • Eczacibasi
  • TTY Biopharm

  • Boryung Pharma
  • Mega Pharm

A PARTNER OF CHOICE

“The best partnerships are those that start with mutual respect of each other’s goals and needs”

30 Years experience in marine biomedicine and 1200 patents granted

History of strong supportive publications and medical meeting presentations

Fully integrated biotech at commercial stage and library of over 250,000 marine compounds

First company in the world to market a marine-derived anticancer drug

Established EU Sales organization of 100 people, including sales, medical sales liaisons, market access, regulatory, tech ops, compliance

Successful regulatory outcomes with FDA, EMA, Swiss Medicines, MHRA (UK)

Partnerships with local champions of the highest quality and successful pricing strategy

Small enough to matter, big enough to care

Our partnerships

Our partnerships are all handled by an Alliance Manager whose job is to align goals, resolve open issues, and mutually move forward in that territory as one.

“The definition of a good alliance is a dynamic and mutually enriching process”
Sonia Vela, Global Alliance Manager

Our partnerships

Something about out-licensing

We have out-licensed our three approved medicines with local champions who can use their experience and resources to maximize the impact we have, within the confines of differences and nuances in culture, regulation, logistics, and protocols.

“We seek local champions with the highest professional integrity for partners”
Arancha Garces, , BDL Department

Something about out-licensing

Something about in-licensing

We are looking for late stage or commercial European assets primarily in oncology to add to our 100 person commercial infrastructure that covers eight major European countries from six offices. In addition, we have local distributors already in place in the remaining parts of Europe. We have over 10 years of successful experience to call on in areas such as regulatory, market access, KOL and hospital relationships, reimbursement, logistics and local customs.

“We are big enough to matter, small enough to care”
Christophe Chevreau, Associate Director, BDL Department

Something about in-licensing

0.3858 seconds.